I NTRO D U C TIO N
The introduction of highly active antiretroviral therapy (HAART) in the treatment of HIV has shown dramatic results, leading to the reduction of mortality and the improvement of the quality of life of PLWHA. (4, 5) However, it has also surfaced new problems such as the development of drug-resistant viral strains and the transmission of resistant strains due to suboptimal adherence in resource-poor settings. (6) In order to prevent the emergence of resistant viral strains, and thus maintain the effectiveness of HAART in the treatment of HIV/AIDS, high levels of motivation and adherence are required from the patient. (7) It has been demonstrated that if adherence to HAART improved by 10%, disease progression will be reduced by 21%. (8) Adherence to HIV treatment regimen is defined as taking all the prescribed pills at the right time, in the right doses and in the right way. (9) After CD4 count, adherence is considered the second strongest predictor of disease progression and chance of survival. (10) Nonadherence raises the risk of therapy failure and developing drug resistance. (11, 12) Although the national ART programme in India was launched in April 2004, there remains limited research and information regarding the levels of adherence and the predictors of suboptimal adherence to treatment among PLWHA. As this information is also lacking in West Bengal, the present study was conducted to determine the pattern of adherence and the possible factors associated with nonadherence to HAART, if any, in a nodal ART centre attached to a tertiary care hospital situated in the Burdwan district in West Bengal, India.
Adherence to highly active antiretroviral therapy in a tertiary care hospital in West Bengal, India
M e Th O Ds
The present study is a hospital-based observational, analytical, cross-sectional epidemiological study conducted between Patients were first briefed about the purpose of the study and assured regarding the confidentiality of the data given. After written consent was obtained from the participants, they were interviewed with the help of a predesigned and pretested schedule, which includes the Adult AIDS Clinical Trial Group adherence questionnaire (ACTGAQ). (15) ACTGAQ is a selfreporting tool used for assessing adherence to HAART. This tool has been extensively used in countries like the United States, (15) northern Italy, (16) Sub-Saharan Africa, (17) and Denmark. (18) It has also been used in many regions in India. (19) (20) (21) HAART-related profiles of the patients were taken from ART cards and medical records. Data regarding sociodemographic characteristics and adherence to HAART were collected using in-depth interviews. The information obtained through the interviews was checked and verified by pill-count. The information from the in-depth interviews was used only if no discrepancy was noted. In the present study, all pill-counts corroborated with the information obtained from the in-depth interviews. Family members of the patients were also interviewed to crosscheck the data obtained regarding adherence.
In this study, adherence is defined as a self-report of not missing a single dose of medication over the previous four days. (15) The time period used to define adherence to HAART varies with different studies, ranging from one day to one month. (22) Since dementia is common among PLWHA, in order to avoid recall bias, a short period of history (i.e. four days) was used for measuring adherence in the present study. Furthermore, if a patient missed a single dose of HAART out of the total eight doses within a four-day schedule, the patient's adherence would be < 95%. This, according to the guidelines set by the National AIDS Control Programme of India (95% has been set as the adherence level), (23) would mean that the patient is considered nonadherent to HAART.
Data was compiled and analysed using Microsoft Excel 
R e sU lT s
The mean age of the 370 patients enrolled in the present study was 33.5 ± 8.5 years. Most of the patients were male and Hindu (58.4% and 88.9%, respectively), 63.2% were from rural areas and 50.8% were educated up to secondary school (i.e. Standard V to X). The percentages of patients who were married, widowed and separated were 83.3%, 12.7% and 1.4%, respectively. In our study population, 33.0% of patients were unemployed, 10.3% were truck drivers and 8.4% were commercial sex workers. A majority of the patients were smokers and 44.1% had addictions (Table I) . were on d4T, 3TC and EFV regimen. Concurrent opportunistic infections were reported in 24.6% of patients, 49.7% of patients had a family history of HIV, and 43.8% had experienced side effects following HAART (Table II) .
In our study, 324 of the 370 (87.6%) patients were adherent to HAART (i.e. did not miss a single dose over the last four days), and the remaining 46 (12.4%) patients were nonadherent.
About 45.7% of the patients never missed any dose throughout HAART. Further analysis revealed that 14.9%, 25.9% and 39.5% patients had missed their dose of HAART within the last one week, one month and three months, respectively. In the last four days, about 7.0% patients missed their full day's medication. While a majority (64.6%) of patients followed the drug schedule most of the time (within the last four days), the drug schedule was followed all the time by only 13.5% of patients. Based on the self-reports and pill-counts, we found that 11.1% patients had < 80% adherence to HAART, and 7.0%
were found to have < 50% adherence (Table III) . (Table V) .
D I sCU s s IO N
The present study was designed to determine the pattern of adherence to HAART and the factors associated with nonadherence in a nodal ART centre in a district of West Bengal, India, where HAART is supplied free of charge. Our results revealed a high level of adherence (87.6%) among adult PLWHA, similar to that reported in other studies conducted in resource-limited settings in India (≈ 90%) (25) and those conducted in other countries (e.g. Senegal 83%-95% (26) and South Africa 93.5% (27) ). In a meta-analysis of ART programmes conducted in resource-poor settings (28) and in studies conducted in Chennai, India, (29, 30) patients receiving HAART free of charge were reported to have a higher adherence to HAART than paying patients. Contradictory findings were reported by Sarna et al's study. (31) In that study, which was conducted in Pune and Delhi, a much lower (81%) adherence to HAART was observed among patients receiving free HAART (through an insurance programme) than paying patients. (31) In the present study, PLWHA aged < 30 years were more nonadherent to HAART than PLWHA aged ≥ 30 years. Similar findings of poorer adherence in younger age groups, especially those aged < 35 years, have also been reported in other studies. (32, 33) Gender was not found to be associated with adherence in our study, similar to that reported by Fogarty et al. (34) The level of education of PLWHA was also not found to be significantly associated with nonadherence in the present study, as was also reported by Cauldbeck et al (35) and Paasche-Orlow et al. (36) Contrary to the findings of the study conducted in Pune and Delhi, (31) the PLWHA in the present study who were employed were more nonadherent to HAART than those who were unemployed. Probable causes of nonadherence among employed PLWHA are busy duty schedules in the workplace and/or forgetfulness. The present study's finding of greater nonadherence to HAART among PLWHA who had experienced side effects to HAART was also observed in other studies. (35, 37) Due to the fear of undesirable side effects, many patients discontinued their medications.
A statistically significant association was found between nonadherence of PLWHA and a positive family history of HIV, consistent with the findings of a study conducted in Nigeria by Igwegbe et al. (38) It seems that when PLWHA have family members who are also suffering from HIV, they lose their hope in life and are thus more reckless, leading to a higher incidence of nonadherence. In the present study's logistic regression analysis, a positive family history of HIV was found to be the strongest predictor of nonadherence to HAART.
In the present study, forgetfulness was the principal reason for missing doses in HAART -a finding that is in line with that of other studies. (5, 18, 38, 39) A majority of PLWHA forgot to take their medicines due to busy schedules, forgetting to bring medicines when away from home, and changed daily routines. Patients on EFV-based regimens were found to be more nonadherent to HAART. This is likely due to the neuro- mutations in the Indian population, (40) as well as the fact that the present study had no scope for EFZ dose reduction (41) according to CYP2B6 carrier status of the patients.
One limitation of the present study is that it was conducted only on patients who attended the ART centre on a regular basis. Patients who dropped out permanently and could not be traced were not included in the study. Therefore, although these patients may have characteristics that differ from those who attended the ART centre regularly, these group of patients were not represented in the data analysis.
Although the overall adherence to HAART was found to be high among the patients from the ART centre in the present study, many of the causes identified to result in nonadherence could be addressed, even in a clinical setting, for better outcome. The factors found to be associated with nonadherence in the present study, such as a positive family history of HIV and the presence of side effects with HAART,
highlight that the quality of counselling in the ART centre needs to be improved. To increase adherence to HAART, patients can be encouraged to use the alarm systems available on their cell phones, or any other device that would be carried with 
